SCHEMBL4204205

SCHEMBL4204205

Cn1ncc(C(N)=O)c1NC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
POLB P06746 1/20 0.41
RIPK2 O43353 1/20 0.41
PDE4B Q07343 2/20 0.41
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PDE4A P27815 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
JAK2 O60674 5/20 0.37
JAK1 P23458 5/20 0.37
TYK2 P29597 5/20 0.37
JAK3 P52333 5/20 0.37
MAP2K1 Q02750 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17853170 0.89 KDM4C (0.42) ALDH1A1POLBKDM4EMAPTVNN1
SCHEMBL27661737 0.84 VNN1 (0.34) ALDH1A1KDM4EHPGDMAPK1KMT2A
SCHEMBL19738133 0.83 RIPK2 (0.41) ALDH1A1RIPK2PDE4BKDM4EHPGD
SCHEMBL6065837 0.82 LPAR1 (0.37) ALDH1A1POLBKDM4EMAPTKMT2A
SCHEMBL5494271 0.82 RIPK2 (0.38) ALDH1A1RIPK2PDE4BKDM4EHPGD
SCHEMBL17853169 0.81 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL6065962 0.80 LPAR1 (0.36) RIPK2MAPTKMT2AVNN1LPAR1
SCHEMBL17853199 0.80 GABRA1 (0.37) ALDH1A1KDM4EKMT2AVNN1LPAR1
SCHEMBL6065942 0.80 VNN1 (0.34) ALDH1A1KDM4EMAPK1VNN1LPAR1
SCHEMBL3113554 0.78 KCNN4 (0.37) HPGDMAPK1VNN1LPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107787324-B Process for preparing carbamoylaminopyrazole derivatives 桑多斯股份公司 2020-05-19 CN disclosed
US-10351533-B2 Process for the preparation of carbamoylamino pyrazole derivatives SANDOZ AG (CH) 2019-07-16 US disclosed
US-10351533-B2 Process for the preparation of carbamoylamino pyrazole derivatives SANDOZ AG (CH) 2019-07-16 US disclosed
EP-3313821-B1 PROCESS FOR THE PREPARATION OF CARBAMOYLAMINO PYRAZOLE DERIVATIVES SANDOZ AG (CH) 2019-04-10 EP disclosed
US-20180305319-A1 Process for the Preparation of Carbamoylamino Pyrazole Derivatives SANDOZ AG (CH) 2018-10-25 US disclosed
CN-107787324-A Process for preparing carbamoylaminopyrazole derivatives 桑多斯股份公司 2018-03-09 CN disclosed
US-20090012054-A1 Cephem Compounds and Use as Antimicrobial Agents ASTELLAS PHARMA INC. (JP) 2009-01-08 US disclosed
EP-1994035-A1 CEPHEM COMPOUNDS AND USE AS ANTIMICROBIAL AGENTS Astellas Pharma Inc. (JP) 2008-11-26 EP disclosed
WO-2007119511-A1 CEPHEM COMPOUNDS AND USE AS ANTIMICROBIAL AGENTS ASTELLAS PHARMA INC. (JP) 2007-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351533-B2 Process for the preparation of carbamoylamino pyrazole derivatives PAICS, PPOX, DDC ALDH1A1 2213/4885POLB 577/4885RIPK2 2437/4885
US-20180305319-A1 Process for the Preparation of Carbamoylamino Pyrazole Derivatives PAICS, PPOX, DDC ALDH1A1 2213/4885POLB 577/4885RIPK2 2437/4885
US-20090012054-A1 Cephem Compounds and Use as Antimicrobial Agents CEP170, Q6ZSR9, H1-10 ALDH1A1 3781/4885POLB 2296/4885RIPK2 1394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.